BD Infusion Sets Updated to the Highest-Risk Recall: How Can Hospital Buyers Isolate Inventory by Model and Use Scenario?
Hospital buyers should locate inventory by catalog number and UDI, isolate affected infusion sets and verify that replacements are compatible with infusion pumps.
On October 5, 2026, the FDA updated recall information for BD Alaris pump infusion sets. The FDA classified the issue as the most serious type of recall. Some infusion sets must be removed from locations where they are used or sold. The notice also stated that performance in different use scenarios may be worse than earlier data indicated, and users may have difficulty identifying the problem in time.
The challenge in medical supply procurement is not a simple choice between stopping all products from a brand and allowing all of them to remain in use. A single product range may include many catalog numbers, filters, tubing materials and connection configurations. Buyers must turn the official list into actions that warehouse and clinical teams can carry out.
Build an accurate model mapping first
Hospitals and distributors should link supplier catalog numbers, unique device identifiers (UDIs), internal item codes and storage locations. Procurement teams must not search by product name alone. Inventory checks should cover the central warehouse, departmental stock, emergency carts and supplies already fitted to equipment.
Teams should retain lot numbers and quantities when isolating stock. The system should prevent recalled item codes from being issued. For models that remain usable but have updated performance data, clinical teams need to read the new instructions and assess flow rates, medication types and patient populations.
Alternatives also need a risk assessment
The FDA recommends using suitable alternative infusion sets and prioritizing critical care, neonatal, infant and pediatric areas when alternatives are limited. Buyers must not select substitutes simply because their connectors match. They need to check tubing materials, filters, low-adsorption performance and pump compatibility.
Suppliers should provide the latest affected-product lists and customer notices. Buyers should also retain notification dates, inventory check results, destruction records and approval records for alternatives.
A checklist buyers can put into practice now
- Map catalog numbers and UDIs to internal item codes.
- Check stock in warehouses, departments and supplies already fitted to equipment.
- Block recalled models in the system.
- Assess the impact by medication, flow rate and patient population.
- Verify the materials and pump compatibility of alternative infusion sets.
- Retain isolation, destruction and alternative-approval records.